Home » Topics » Disease categories and therapies » Urology

Urology
RSS

Two pivotal phase III trials of Alprox-TD completed

Dec. 18, 2002

RenaZorb begins testing in animals

Dec. 12, 2002

European approval for Avodart for benign prostatic hyperplasia

Dec. 11, 2002

Lilly and Boehringer Ingelheim sign cocommercialization agreements for duloxetine

Dec. 10, 2002

Lilly Icos presents new PDE5 inhibitors for male and female sexual dysfunction

Dec. 9, 2002

Marketing authorization application submitted for Striant in U.K.

Dec. 9, 2002

ZP-120 completes phase I trial

Dec. 9, 2002

Kissei licenses KUC-7483 to Boehringer Ingelheim

Dec. 2, 2002

Ortho Biotech licenses bone morphogenetic protein technology

Nov. 29, 2002

Effective agents for nephritis without cardiovascular side effects designed at Tanabe Seiyaku

Nov. 28, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 28, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...